ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 8, 2000, Pages 1990-1997

  Minihane, Anne M ^a   Khan, Syrah ^c   Leigh Firbank, Elizabeth C ^a   Talmud, Philippa ^b   Wright, John W ^c   Murphy, Margaret C ^c   Griffin, Bruce A ^c   Williams, Christine M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

ApoE genotype; Atherogenic lipoprotein phenotype; Fish oils; Plasma lipids

Indexed keywords

APOLIPOPROTEIN E; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSLIPIDEMIA; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; MALE; NORMAL HUMAN; PHENOTYPE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033840462     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.8.1990     Document Type: Article

References (70)

1. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: A meta analysis of population based studies
2. Postprandial dyslipidaemia: A risk factor for coronary heart disease
3. Plasma triglycerides and coronary heart disease
4. Postprandial lipid metabolism in relation to coronary heart disease
5. Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary heart disease
6. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immuno-sorption from human atherosclerotic plaque
7. Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk
8. Low density lipoprotein subclasses: Mechanism of formation and modulation
9. Dense low-density lipoproteins and coronary artery disease
10. Low density lipoprotein subclass patterns and risk of myocardial infarction
11. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary heart disease risk
12. Influence of dietary fatty acids on the atherogenic lipoprotein phenotype
13. Characterization of low-density lipoprotein subclasses: Methodologic approaches and clinical relevance
14. n-3 fatty acids and serum lipoproteins: Human studies
15. Postprandial lipid metabolism: Effects of dietary fatty acids
16. The effects of salmon oil upon plasma lipids, lipoproteins, and triglyceride clearance
17. Dietary polyunsaturated fatty acids of the ω-6 and ω-3 series reduce postprandial lipoprotein levels
18. Reduction of post-prandial triglyceridaemia in humans by dietary n-3 fatty acids
19. Effects of n-3 fatty acids on postprandial triglyceride and hormone concentrations in normal subjects
20. The genetics of serum lipid responsiveness to dietary interventions
21. Apolipoprotein genes and atherosclerosis
22. Lipoprotein and lipid metabolism disorders: Structure and metabolism of plasma lipoproteins
23. Apolipoprotein E polymorphism and atherosclerosis
24. The use of measured genotype information in the analysis of quantitative phenotypes in man, II: The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals
25. Apolipoprotein E polymorphism and coronary artery disease
26. Modulation of plasma triglyceride levels by apoE phenotype: A meta analysis
27. Clearance of postprandial lipoproteins in normolipemics: Role of the apolipoprotein E phenotype
28. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations
29. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein E4 allele
30. The effect of fasting triglyceride concentration and apolipoprotein E polymorphism on postprandial lipaemia
31. Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E
32. +2 high-density lipoprotein cholesterol precipitation method for use with previously frozen plasma
33. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
34. Lipolytic enzymes and plasma lipoprotein metabolism
35. Rapid isolation of low density lipoprotein subfractions from plasma by density gradient ultracentrifugation
36. N-3 fatty acids in Indian diets: Comparison of the effects of precursor alpha-linolenic acid vs product long-chain n-3 poly-unsaturated fatty acids
37. A simple method for the isolation and purification of total lipids from animal studies
38. Separation of neutral lipid, free fatty-acid and phospholipid classes by normal phase HPLC
39. A method for the rapid determination of hundreds of apoE genotypes, combining simplified, optimised protocols from sample acquisition to PCR and restriction digestion analysis by microplate array diagonal gel electrophoresis (MADGE)
40. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease
41. Apolipoprotein E alleles, dyslipidaemia, and coronary heart disease: The Framingham Offspring Study
42. Hepatic uptake of chylomicrons remnants
43. Site-specific mutagenesis of human apolipoprotein E: Receptor binding activity of variants with single amino acid substitutions
44. Abnormal lipoprotein receptor-binding activity on the human apoprotein due to cysteine-arginine interchange at a single site
45. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipaemia in man
46. Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations
47. Composition of human low density lipoprotein: Effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein
48. Abnormal in vivo metabolism of apolipoprotein E4 in humans
49. Apolipoprotein E distribution among human plasma lipoproteins: Role of the cysteine-arginine interchange at residue 112
50. Interactions between lifestyle-related factors and the apoE polymorphism on plasma lipids and apolipoproteins: The EARS Study
51. Modulation by apolipoprotein E of lipoprotein lipase activity
52. Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: Evidence for a lactoferrin-sensitive and apolipoprotein-independent pathway
53. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype
54. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E
55. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review
56. Suppression by diets rich in fish oil of very low density lipoprotein production in man
57. Dietary fish oils inhibit early events in the assembly of very low density lipoproteins and target apoB for degradation within the rough endoplasmic reticulum of hamster hepatocytes
58. Comparison of C-18, C-20, and C-22 unsaturated fatty acids in reducing fatty acid Synthesis in isolated rat hepatocytes
59. Postheparin lipolytic activity and plasma lipoprotein response to n-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia
60. Effects of dietary fatty acid composition on postprandial insulin, GIP and lipoprotein lipase activity
61. 1-3
62. Non-esterified fatty acid metabolism and postprandial lipaemia
63. Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil
64. Metabolic heterogeneity in very low density lipoproteins
65. Fish oil attenuates the cholesterol-induced rise in lipoprotein cholesterol
66. Effect of pravastatin and ω-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyper-lipidaemia
67. Effect of fish oil on LDL size, oxidizability and uptake by macrophages
68. Effects of eicosapentaenoic acid on plasma lipoprotein subfractions and activities of lecithin: Cholesterol acyltransferase and lipid transfer protein
69. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia